Astrazeneca (AZN) Liabilities from Discontinued Operations (2011)

Astrazeneca (AZN) recorded quarterly Liabilities from Discontinued Operations of 196000000.0 in Q2 2011.

Astrazeneca (AZN) Liabilities from Discontinued Operations (2011) Analysis & Trends

Astrazeneca's Liabilities from Discontinued Operations history runs 1 years deep, the most recent figure standing at 196000000.0 for Q2 2011.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Gsk	92,316,836.42 Bn	92,316,831.46 Bn	7.76 Bn
2	Eli Lilly	983.57 Bn	978.29 Bn	16.22 Bn
3	Johnson & Johnson	553.56 Bn	531.50 Bn	15.96 Bn
4	AbbVie	383.35 Bn	374.00 Bn	10.78 Bn
5	Merck	281.71 Bn	276.06 Bn	12.09 Bn
6	Amgen	182.20 Bn	170.16 Bn	5.87 Bn
7	Gilead Sciences	153.71 Bn	145.98 Bn	5.52 Bn
8	Pfizer	143.75 Bn	130.98 Bn	-1.21 Bn
9	Bristol Myers Squibb	109.71 Bn	99.25 Bn	8.07 Bn
10	Astrazeneca	67.83 Bn	59.89 Bn	12.61 Bn

Download Data

Date	Value
Jun 30, 2011	-196.00 Mn
Jun 30, 2011	-196.00 Mn